BRAF Mutant Metastatic Melanoma
1 clinical trials · Condition
◉ Watch BRAF Mutant Metastatic Melanoma
| Record | Firm | Date |
|---|---|---|
| BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma (NCT01512251) | University of California, San Francisco | 2012-06-09 |
Track BRAF Mutant Metastatic Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.